Population pharmacokinetics of ε-aminocaproic acid in adolescents undergoing posterior spinal fusion surgery

British Journal of Anaesthesia

Volumn 114, Issue 4, 2015, Pages 689-699

  Stricker, P A ^a   Gastonguay, M R ^b   Singh, D ^a   Fiadjoe, J E ^a   Sussman, E M ^a   Pruitt, E Y ^a   Goebel, T K ^a   Zuppa, A F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Metrum Institute   (United States)

Author keywords

antifibrinolytic agents; paediatrics; pharmacology; scoliosis; spinal fusion

Indexed keywords

AMINOCAPROIC ACID;

ADOLESCENT; ADOLESCENT IDIOPATHIC SCOLIOSIS; ADULT; ANESTHESIA INDUCTION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CRANIOFACIAL SURGERY; DOSE CALCULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; FEMALE; HUMAN; INFANT; LOADING DRUG DOSE; MALE; PLASMA CLEARANCE; POSTERIOR SPINE FUSION; PRIORITY JOURNAL; SCOLIOSIS; SPINE SURGERY; AGE; BIOLOGICAL MODEL; SPINE FUSION;

ADOLESCENT; AGE FACTORS; AMINOCAPROIC ACID; CHILD; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; SPINAL FUSION;

EID: 84926659181     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu459     Document Type: Article

References (26)

1. Thompson GH, Florentino-Pineda I, Poe-Kochert C, Armstrong DG, Son-Hing J. Role of amicar in surgery for neuromuscular scoliosis. Spine (Phila Pa 1976) 2008; 33: 2623-9
2. Florentino-Pineda I, Thompson GH, Poe-Kochert C, Huang RP, Haber LL, Blakemore LC. The effect of amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized, double-blind study. Spine 2004; 29: 233-8
3. Verma K, Errico T, Diefenbach C, et al. The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial. J Bone Joint Surg 2014; 96: e80
4. Dhawale AA, Shah SA, Sponseller PD, et al. Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis? Spine (Phila Pa 1976) 2012; 37: E549-55
5. Florentino-Pineda I, Blakemore LC, Thompson GH, Poe-Kochert C, Adler P, Tripi P. The effect of epsilon-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion. Spine (Phila Pa 1976) 2001; 26: 1147-51
6. Thompson GH, Florentino-Pineda I, Armstrong DG, Poe-Kochert C. Fibrinogen levels followingamicar insurgery for idiopathic scoliosis. Spine (Phila Pa 1976) 2007; 32: 368-72
7. Thompson GH, Florentino-Pineda I, Poe-Kochert C. The role of amicar in decreasing perioperative blood loss in idiopathic scoliosis. Spine (Phila Pa 1976) 2005; 30: S94-S9
8. Thompson GH, Florentino-Pineda I, Poe-Kochert C, Armstrong DG, Son-Hing JP. The role of amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis. Spine (Phila Pa 1976) 2008; 33: 2237-42
9. Nilsson IM, Sjoerdsma A, Waldenstrom J. Antifibrinolytic activity and metabolism of 6-aminocaproic acid in man. Lancet 1960; 1: 1322-6
10. Bennett-Guerrero E, Sorohan JG, Canada AT, et al. Epsilonaminocaproic acid plasma levels during cardiopulmonary bypass. Anesth Analg 1997; 85: 248-51
11. Frederiksen MC, Bowsher DJ, Ruo TI, Henthorn CT, Green D, Atkinson AJ. Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects. Clin Pharmacol Ther 1984; 35: 387-93
12. Butterworth J, James RL, Lin Y, Prielipp RC, Hudspeth AS. Pharmacokinetics of epsilon-aminocaproic acid in patients undergoing aortocoronary bypass surgery. Anesthesiology 1999; 90: 1624-35
13. Butterworth J, James RL, Lin YA, Bennett J, Prielipp RC. Gender does not influence epsilon-aminocaproic acid concentrations in adults undergoing cardiopulmonary bypass. Anesth Analg 2001; 92: 1384-90
14. Fish SS, Pancorbo S, Berkseth R. Pharmacokinetics of epsilonaminocaproic acid during peritoneal dialysis. J Neurosurg 1981; 54: 736-9
15. Stricker PA, ZuppaAF, Fiadjoe JE, et al. Populationpharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery. Br J Anaesth 2013; 110: 788-99
16. Anderson BJ, McKee AD, Holford NH. Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clin Pharmacokinet 1997; 33: 313-27
17. West GB, Brown JH, Enquist BJ. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999; 284: 1677-9
18. Harrell F. Regression Modeling Strategies. New York: Springer-Verlag, 2001
19. Ribbing J, JonssonEN. Power, selection biasandpredictiveperformance of the population pharmacokinetic covariate model. J Pharmacokinet Pharmacodyn 2004; 31: 109-34
20. Alkjaersig N, Fletcher AP, Sherry S. Epsilon-aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem 1959; 234: 832-7
21. Ablondi FB, Hagan JJ, Philips M, DeRenzo EC. Inhibition of plasmin, trypsin, and the streptokinase-activated fibrinolytic system by epsilon-aminocaproic acid. Arch Biochem Biophys 1959; 82: 153-60
22. Ririe DG, James RL, O'Brien JJ, et al. The pharmacokinetics of epsilon-aminocaproic acid in children undergoing surgical repair of congenital heart defects. Anesth Analg 2002; 94: 44-9
23. Goobie SM, Meier PM, Pereira LM, et al. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebocontrolled trial. Anesthesiology 2011; 114: 862-71
24. Nielsen VG, Cankovic L, Steenwyk BL. Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered? Blood Coagul Fibrinolysis 2007; 18: 35-9
25. Dvorchik BH, Katlic KL, Hayes AH Jr, Eyster ME. Effect of probenecid on the kinetics of epsilon-aminocaproic acid. Clin Pharmacol Ther 1980; 28: 223-8
26. McNicol G, Fletcher A, Alkjaersig N, Sherry S. The absorption, distribution, and excretion of epsilon-aminocaproic acid following oral or intravenous administration to man. J Lab Clin Med 1962; 59: 15-24